Thus, the RdRP-specific primers could produce an amplicon from SARS-CoV-1 that can be readily distinguished based on sequence analysis, while the Spike-specific primers, targeting the RBD and Polybasic site regions, would distinguish a SARS-CoV-2 infection. This evidence concerns the gene CHMP5 and COVID-19.